Skip to main content

All Publications

Joseph Panoff, Miami Cancer InstituteFollow

Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1

Publication Date

6-1-2021

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

Transplant Cell Ther (2021) 27(6).

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS